DIALYSIS · CCN 392809

DaVita City Line Dialysis

Philadelphia, PA 19131

DialysisProfitDaVita
$3.6M
TOTAL REVENUE
5.7%
OPERATING MARGIN
4 / 5
STAR RATING
13
QUALITY MEASURES
DaVita
CHAIN
01 — FINANCIAL

Cost report financials (FY2025)

Net patient revenue
$3.6M
Total costs
$3.4M
Operating income (rev − costs)
$203K
Operating margin
5.7%
Total charges
$3.7M
Total treatments
10,212
Dialysis stations
17

Source: CMS dialysis cost reports. Operating margin = (net patient revenue − total costs) / net patient revenue.

02 — QUALITY MEASURES

13 quality measures

MeasureScoreDenominatorPeriod
Standardized ED Visits Within 30 Days of Hospital Discharge
DFC_ED30
0.5930—
Fistula Rate
DFC_FISTULA_RATE
63.978—
Five Star Rating
DFC_FIVE_STAR
4——
First Year Standardized Kidney Transplant Waitlist Ratio
DFC_FYSWR
023—
Healthcare Worker COVID-19 Vaccination Adherence
DFC_HCP_VACC
1——
Patient Hospitalization Rate
DFC_HOSPITALIZATION_RATE
78.865—
Standard Infection Ratio (SIR)
DFC_INFECTION_RATIO
0——
Percentage of Adult Patients with Long Term Catheter in Use
DFC_LONG_CATHETER
1478—
Patient Survival (Mortality Rate)
DFC_MORTALITY_RATE
12.6261—
Percentage of Prevalent Patients Waitlisted for Kidney Transplant
DFC_PPPW
31.953—
Patient Hospital Readmission Rate
DFC_READMISSION_RATE
31.828—
Standardized ED Visits Ratio
DFC_SEDR
1.1129—
Patient Transfusion Rate
DFC_TRANSFUSION_RATE
627—